Different Doses of Sirolimus for the Treatment of Cystic Lymphatic Malformations

NCT06673290 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Lymphatic Malformation

Interventions

DRUG: Sirolimus (RAPAMUNE)

Sponsor

West China Hospital